Post by
Deepinvestor on Feb 12, 2016 10:08am
TST
Stock price movement is totally normal with this News release. A lot of previous bad news made it hard to have trust in TST. However, it is currently under evaluated, phase 3 does not mean a refusal, FDA simply would like to test mcna on more patience just to make sure it is fully functional before licensing it. In my opinion, Stock price will slightly increase this afternoon and so on Monday. Let's all wish the best for TST and all current share holders as if this project gets approved, TST is turning into multi millions company. GLTA!
Comment by
DamnYankees on Feb 12, 2016 10:34am
The NR reads like the company was completely taken aback by the FDA ruling. Really? no one else was. I think that the result was exactly "as expected", with some retail scrubs trading back and forth after Adcomm but no sustained confidence in anything but a NO decision. Lets hope that their "partners" and "investors" keep things are a short leash.